-5%
Empagliflozin + Linagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is also prescribed to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease.
Empalina 25/5 Tablet is a combination of Empagliflozin and Linagliptin, used to manage type II diabetes mellitus among adult patients when conventional methods like diet, exercise, and other medications are not sufficient for adequate sugar control. It is also used as adjunct therapy in patients with diabetes and heart problems.Â
Follow proper hygiene and regular foot care as instructed by your doctor while taking Empalina 25/5 Tablet. Regularly monitor your blood glucose levels as instructed by your doctor.
Inform your doctor if you have any liver or kidney problems, or if you have been severely dehydrated due to excessive vomiting or diarrhea recently. Empalina 25/5 Tablet is not recommended for use in patients with Type I diabetes, alcoholism, or diabetic ketoacidosis.